Ha Tay Pharmaceutical JSC announced a private placement of 8,400,000 common shares at a price of VND 21,500 each for gross proceeds of VND 180,600,000,000 on December 21, 2023. The transaction included participation from returning investor ASKA Pharmaceutical Holdings Co.,Ltd. The company incurred issue expenses of VND 280,000,000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
35,800 VND | +0.28% | +23.45% | +55.65% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
35,800 VND | +0.28% | +23.45% | 120M | ||
2,315 JPY | -1.11% | +10.13% | 443M | ||
1st Jan change | Capi. | |
---|---|---|
+55.65% | 120M | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- DHT Stock
- News Ha Tay Pharmaceutical
- Ha Tay Pharmaceutical JSC announced that it has received VND 180.6 billion in funding from ASKA Pharmaceutical Holdings Co.,Ltd.